NEW
YORK, Jan. 30, 2025 /PRNewswire/ -- The Gross
Law Firm issues the following notice to shareholders of Novo
Nordisk A/S (NYSE: NVO).
Shareholders who purchased shares of NVO during the class period
listed are encouraged to contact the firm regarding possible lead
plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/novo-nordisk-a-s-loss-submission-form/?id=125764&from=4
CLASS PERIOD: November 2,
2022 to December 19, 2024
ALLEGATIONS: According to the complaint, on December 20, 2024, Novo issued a press release
announcing the below-expected results of their "REDEFINE 1" trial,
"a 68-week efficacy and safety trial investigating subcutaneous
CagriSema." The trial showed that patients treated with CagriSema
exhibited weight loss of 22.7% after 68 weeks, well short of Novo's
targeted expectation of at least 25% weight loss. The press release
further indicated that participant patients were permitted to
modify their own dosage during the trial and, as a result, only
57.3% of patients treated with CagriSema were on the highest dosage
contemplated by the study. Following this news, Novo's stock
price fell by $18.44 per share to
close at $85.00 per share.
DEADLINE: March 25, 2025
Shareholders should not delay in registering for this class action.
Register your information here:
https://securitiesclasslaw.com/securities/novo-nordisk-a-s-loss-submission-form/?id=125764&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of NVO during the timeframe listed
above, you will be enrolled in a portfolio monitoring software to
provide you with status updates throughout the lifecycle of the
case. The deadline to seek to be a lead plaintiff is March 25, 2025. There is no cost or obligation to
you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross
Law Firm is committed to ensuring that companies adhere to
responsible business practices and engage in good corporate
citizenship. The firm seeks recovery on behalf of investors who
incurred losses when false and/or misleading statements or the
omission of material information by a company lead to artificial
inflation of the company's stock. Attorney advertising. Prior
results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nvo-lawsuit-alert-the-gross-law-firm-notifies-novo-nordisk-as-investors-of-a-class-action-lawsuit-and-upcoming-deadline-302363954.html
SOURCE The Gross Law Firm
